Introduction
The use of biotin-avidin systems in histochemistry has become widespread because of their applicability in many ways. Biotin can be attached to a variety of compounds and then detected by binding it with high affinity and specificity to avidin which, in turn, is coupled to an enzyme, colloidal gold, or a fluorochrome. A means of enhancing the sensitivity of biotin-avidin systems in solid-phase assays was recently reported by Bobrow et al. (2) . The method employs HRP to catalyze the deposition of biotinylated tyramine onto proteins attached to the substrate. The binding of the tyramine to proteins at or near the site of HRP activity is believed to be due to the production of free radicals by the oxygen that is liberated by the HRP. The biotin sites on the bound tyramine are subsequently used for attachment of avidin, which is conjugated to HRP. This HRP is then used to catalyze a color reaction. In the present study the method of Bobrow et al. is applied to histochemistry and its advantages shown for neuroanatomical tracing methods, for lectin histochemistry, and for immunohistochemistry. mits much shorter incubations in primary antibodies when dilutions are used that would ordinarily be used with conventional bridge techniques. The procedure is also useful for amplifying very weak signals, such as those of immunoreactions in glutaraldehyde-fmed tissue. The amplification procedure, together with the availability of avidin probes labeled with fluorochromes, colloidal gold, or enzyme systems other than HRP, provides a means of greatly increasing the versatility of a variety of histochemical reactions, including those for detecting in situ hybridization probes, in addition to increasing the sensitivity of the reactions. (J Hisrochem Cytochem 40:1457-1463, 1992) KEY WORDS: Biotin amplification; Immunohistochemistry; Lectin histochemistry.
Materials and Methods
Tissue Preparation. The tissue used in this work included frozen brain sections, 20-80 pm thick, and temporal bones that had been fixed concurrently with the brains, decalcified in EDTA or formic acid, embedded in paraffin, cut at 5 pm, and mounted on slides. The species represented included human, cat, rat, rabbit, guinea pig, and gerbil. Fixation was achieved with various mixtures of formaldehyde and zinc salts (7) and mixtures of formaldehyde and glutaraldehyde. The human tissue was fixed by immersion and other species were fixed by vascular perfusion.
Injected Peroxidase. The usefulness of the method as applied to anatomic pathway tracing was tested on brain sections from two cats in which a 10% solution of biotinylated HRP (bHRP) (Sigma; St Louis, MO) was either injected into the primary auditory cortex or placed into the scala tympani of the cochlea. Institutional guidelines for the use of animals were followed. The animals were deeply anesthetized with urethane (2.5 g/kg, IP) throughout the entire experiment. After the injections, the animals were allowed to survive 24 hr before being perfused with a mixture of 0.2% glutaraldehyde and 4% freshly depolymerized paraformaldehyde in 0.1 M phosphate buffer (pH 7.3), or with 10% formalin in saline with 0.5% zinc salicylate added and the pH adjusted to 6.5. The brains were infiltrated with 25% sucrose and frozen sections cut at 20 or 40 pm. The retrogradely labeled neurons were visualized by the conventional diaminobenzidine (DAB) method (4), which was modified by the use of phosphate buffer, and by the addition of nickel and cobalt salts to render the reaction product black (1). Other sections were processed by first treating them in a solution of avidin-biotin-HRP (Standard ABC kit) (Vector; Burlingame, CA) before the black DAB reaction. The experimental sections were treated in an amplification step using the injected bHRP to produce the amplification or after an ABC treatment which bound ABC to the injected bHRP and thereby increased the number of HRP sites that catalyzed the amplification step. After the amplification step the sections were processed in ABC or streptavidin-HRP (1:2000) (New England Nuclear; Boston, MA) and then processed for the black DAB reaction. Sections from a rabbit brainstem were also processed. This animal was treated similarly to the cats except that a saturated solution of biotinylated wheat germ agglutinin (bWGA) was placed on the proximal stump of a severed facial nerve. The primary use of this tissue was to evaluate the effectiveness of various procedures for enhancing the detection of a tissue-bound lectin, but the retrogradely transported bWGA was also visualized. The brains of additional cats and other species were fixed with different concentrations of glutaraldehyde and 4% paraformaldehyde, with formaldehyde and zinc salts (7) , or with formaldehyde alone and processed to compare immunostaining of tissue fixed with the different fixatives.
Amplification Procedure. The amplification procedure consisted of a 10-min incubation in 0.01% H202 and biotinylated tyramine (BT), whose concentration was systematically varied. The concentration of H202 was always 0.01% and the incubation in BT-H202 was always 10 min. The BT was obtained from New England Nuclear (BLAST kit) or made by combining near equimolar amounts of tyramine-HCI (Sigma) and sulfosuccinimidyl-6-(biotinimide) hexanoate (NHS-LC-biotin) (Pierce; Rockford, IL) in 50 mM borate buffer (pH 8.0) with agitation overnight at room temperature and then filtering through a 0.45-pm syringe filter. To ensure that there was a slight excess of tyramine over biotin, the buffer was added to the NHS-LC-biotin until the solution remained slightly cloudy (40 ml buffer added to 100 mg NHS-LC-biotin) and then tyramine (31.2 mg) was added. It was not possible to know the exact Concentration of biotinylated tyramine in samples that were made as described (the approximate concentration was 7 pM), but comparisons were made of the BT from the commercial source and that made as described. No differences between the two were apparent in effect or concentration, so it was assumed that the commercially obtained BT and that made as described were both saturated solutions. After initial comparisons of BT from the two sources, most experiments were done with that made as described above for reasons of economy. Preliminary comparisons were made between the effectiveness of ABC vs streptavidin-HRP (New England Nuclear and Vector). No obvious differences were noted between the sensitivity of the two, but delicate structures appeared to be better delimited when ABC was employed, so most tissue was processed in ABC.
Lectin Histochemistry. The effects of the procedures under study on lectin staining were studied using biotinylated lectin from Vicla udfo.ra (bWA) (Sigma) and its binding to rabbit and cat brainstem sections. Sections were incubated in serial limiting dilutions of the lectin diluted with 1% bovine serum albumin (Sigma) in 0.01 M PBS. All sections were incubated (with agitation) in bVVA for 1 hr at room temperature. Comparisons were made between the lectin visualized by incubating sections in ABC and then DAB or by an amplified biotin method. The primary approach was the same as described for detecting the injected biotinylated HRP. After the bWA incubation, the sections were processed as follows: ABC 30 min, 10 pllml BT-HzOz 10 min. ABC 30 min, DAB. Each step in all procedures described herein was followed by washing of sections in PBS with a minimum of five changes over 10 min. Reported dilutions were arrived at by serial twofold dilution series.
hunohistochemistry. The effects of the biotin amplification on the sensitivity of immunohistochemical procedures were tested using some two dozen monoclonal and serum antibodies raised against a variety of cytosolic and membrane-bound antigens. Free-floating frozen sections of brain and paraffin-embedded sections of cochlea were processed with a biotinylated secondary antibody, followed by ABC and then DAB (6). Comparisons were made between sections processed in this manner with those that had a biotin amplification step after the ABC. This was followed by another ABC step to bind the amplified biotin sites. The sensitivity of conventionally immunostained tissue was usually enhanced by the addition of nickel and cobalt salts to the DAB solution (1) . This involves creating a DAB solution in 0.1 M phosphate buffer and saturating this solution with nickel and cobalt salts. Just before use the solution is filtered through a 0.45-pm syringe filter. The addition of the metal ions to the DAB was avoided in the amplified biotin procedures because the biotin amplification caused the DAB polymerization to proceed very rapidly and this could create a problem of background staining if the reaction were additionally enhanced by metal salts.
Amplification of the Amplifier. Three means of further amplifying the biotin amplification were compared. These experiments were done using detection of tissue-bound bWA as the assay. Free-floating sections of brainstem were incubated in serial dilutions of bWA as described above to determine the greatest dilution that yielded detectable staining after different amplification procedures. The first procedure was to recycle the amplification step. This was done as follows: bWA 1 hr, ABC 30 min, BT-H202 (5 pl BT/ml) 10 min, ABC 30 min, BT-H202 ( 5 pl BT/ml) 10 min, ABC 30 min, DAB. The solutions were reused in subsequent cycles. Two other procedures for amplifying the biotin amplification were evaluated. The first consisted of coupling the biotin of the bound bWA with ABC, using the ABC to amplify the biotin sites with BT, then detecting those sites by immunostaining for biotin. The second employed immunostaining for the biotin in the bVVA and then amplifying the immunostain with the BT procedure. The procedures were done as follows. First method: after the initial bWA, ABC 30 min, BT-H202 (10 pl BT/ml) 10 min, 1:20,000 goat anti-biotin (Sigma) 1 hr, 1:200 biotinylated rabbit anti-sheep IgG (Vector) 1 hr, ABC 30 min, DAB. The second method: after initial bWA, 1:20,000 goat anti-biotin (Sigma) 1 hr, 1:5000 biotinylated rabbit anti-sheep IgG (Vector) 1 hr. ABC 30 min, BT-H202 (10 pl BT/ml) 10 min, ABC 30 min, DAB. The BT was usually diluted in PBS. In some cases the sections stuck to the container in the BT step. An attempt to prevent this sticking was made by diluting in bovine serum albumin (Sigma, RIA grade), but this resulted in a reduction of the amplified signal and an increase in background staining and was therefore discontinued.
Results
The amplification of biotin sites in the tissue by the catalytically driven deposition of BT resulted in a tremendous increase in sensitivity in the detection of injected bHRP, of the biotinylated lectin, and in the detection of antigens immunohistochemically. The increase appeared to be equally effective regardless of the species from which the tissue was taken or whether slide-mounted, paraffinembedded sections or free-floating sections were used. In the case of the injected bHRP, the main result was that the sites of HRP activity were far easier to detect. In the cases of the lectin binding and immunohistochemistry, the most obvious effect was a great increase in background staining when dilutions that would have been necessary for conventional methods were employed. This appeared to be due to the visualization of previously undetected nonspecific binding of the lectin and immunoreagents. By contrast, with much higher dilutions of the reagents the amplified method produced a much improved signal-to-noise ratio as compared with conventional methods, and the strength of the signal was as good or better than obtained with conventional methods.
There was a clear relationship between the degree of amplification achieved and the concentration of BT employed. For detec- tion of injected bHRP, the greatest concentration of BT that was useful before background staining became a problem was 25 pllml. The least amount for which an effect was readily apparent was 2 pllml. Figure 1 illustrates the effect of the biotin amplification on detection of retrogradely transported bHRP. Figure 1A shows neurons within the hilus of the lateral superior olive (lateral olivocochlear cells) that were retrogradely labeled by the HRP placed in the cochlea and visualized with only the black DAB reaction. Demonstration of this projection using HRP was first reported by Warr (9) and the system was chosen for the present purposes because of its relative simplicity. Figure 1B shows neurons in a nearby section that were visualized after treating the sections in BT (25 pl/ml), followed by ABC and then black DAB. Further enhancement of the amplification was achieved by the sequence ABC, BT, ABC, DAB, because the additional HRP from the first ABC step helped drive the biotin amplification (data not shown). The HRP sites within the cytoplasm were much more obvious in the amplified tissue, and fme axonal and dendritic processes of the labeled neurons also became visible ( Figure 1B ). An even more dramatic effect of the amplification is illustrated in Figure IC , which shows the auditory nerve and its terminals in the nerve root region of the cochlear nucleus of the same case. Great care was taken when the injection was made to avoid physical damage to the organ of Corti, so that any HRP found in the eighth nerve fibers was assumed to have been taken up by undamaged fibers. With the conventional DAB procedure only a few fibers were positive. They were lightly labeled and confined to the nerve root region and no terminals were visible. Figure 1C shows a large, complex primary nerve ending in the nerve root region of the cochlear nucleus that was made visible by the BT amplification. In addition to large fibers and endings, the BT amplification made fine terminals of the most distant projections of the eighth nerve in the dorsal portion of the dorsal cochlear nucleus visible ( Figure 1D ). Perhaps the most impressive effect of the amplification procedure was that groups of cells that had been processed by the BT amplification method could be seen with the unaided eye, whereas cells in adjacent sections that were processed by the conventional method could be seen only with the aid of a microscope using a x40 objective. The usefulness of the black DAB reaction product was apparent in examining sections containing injected HRP whose presence was detected after BT amplification. When comparisons were made of nearby sections that had been amplified identically except for the black vs brown reaction product, it was obvious that the black cells were far easier to locate when scanning the sections with low power objectives. Figures 2A and 2B show a comparison of bWA binding of cells in the reticular formation of the cat medulla processed by ABC and DAB vs ABC, BT (10 pllml), ABC, DAB. The density of the labeled processes is approximately the same for the two sections, but the background staining is much higher in the conventionally processed method. The dilution of the bWA for the amplified method was 1:500,000 (w/v) ( Figure 2B ) as compared with 15000 for the conventional method (Figure 2A) .
Much of the evaluation of the amplification procedure for demonstrating bound bWA was done on sections from the rabbit in which bWGA had been placed on the proximal stump of the severed facial nerve. The same procedures utilized for visualization of the bVVA were equally effective for demonstration of the retrogradely transported bWGA that was within the facial motor neurons (not shown).
The effects of BT amplification are more difficult to demonstrate when applied to immunohistochemistry but they are no less dramatic than those shown above. Amplification with BT was found for all antibodies and for all fixatives, but not for all combinations of these. The primary factor that required adjustment in the immunostaining protocols with the amplified procedure was the dilution of the primary antibody. The dilution had to be much greater than with conventional bridge techniques, but the optimal dilution varied greatly among different antibodies. The range of optimal dilutions encountered thus far with 24 different antibodies varied from five-to 200-fold. The factors that determine the optimal dilution are not yet obvious. An illustration of the intensity of staining that was achieved with an extremely diluted primary antibody is shown in Figure 2C . In this case the primary antibody was a rat monoclonal antibody against substance P (Accurate; Westbury, NY) and was used at a dilution of 1:1,000,000 overnight at room temperature. This dilution was approximately 100-fold more than that required to produce equivalent staining intensity when the conventional ABC method was employed.
The increased sensitivity provided by the BT amplification of immunostaining was dramatically illustrated when glutaraldehydefixed tissue was processed. For many antibodies it is usually necessary to minimize or to entirely eliminate glutaraldehyde from fixatives to obtain useful results. Preliminary results with several antibodies indicate that the weakness of the signal found in glutaraldehydefixed tissue can in some cases be overcome by the BT amplification method. Figure 2D shows neurons in the ventral portion of the medial periolivary region of the cat medulla that have been immunostained for met-enkephalin (Incstar; Stillwater, MN). The tissue was fixed for 1 hr in a mixture of 0.5% glutaraldehyde and 4% paraformaldehyde. Nearby sections processed with the same antibody and the same dilution by the conventional ABC method showed only weakly positive cells ( Figure 2E ). Another remarkable feature of this result was that when this antibody was used to immunostain these cells in tissue fixed only with formalin, it was necessary to topically inject colchicine on the day before the animal was perfused to force the accumulation of extra antigen within the neurons by blockage of axoplasmic transport. Equivalent effects were also found with antisera to neurotensin (Incstar) and to glutamate decarboxylase (8) . For both antisera, neurons were clearly visualized in glutaraldehyde-fixed tissue when the BT amplification procedure was used without colchicine. In formalin-fixed tissue, when the conventional ABC procedure was employed it was necessary to inject colchicine to immunostain the corresponding neurons with these antisera. Different results were seen with antisera to other peptides. No colchicine-like effect in glutaraldehyde-fixed sections was seen with an antiserum to galanin (Peninsula Laboratories; Belmont, CA) although there was a clear enhancement of staining with the use of BT. On the other hand, virtually no immunostaining was seen with any method when an antiserum to cholecystokinin (Incstar) was used on glutaraldehyde-fixed tissue, whereas successful immunostaining was achieved with the use of formaldehyde alone as a fixative.
With standard immunostaining protocols the background staining prevents long incubations in DAB to produce the color reac-B D E - (C) Frontal section of the inferior colliculus of cat immunostained for substance P with BT amplification. The dilution of the primary antibody was 1:1.000,000.
Fixative was 10% formalin with 0.5% zinc salicylate, pH 6.5. (D) Neurons in the medial portion of the ventral periolivary region of cat brainstem immunostained with BT amplification for met-enkephalin, primary antibody dilution 1:20,000. Fixative was 0.5% glutaraldehyde and 4% paraformaldehyde. (E) Same as D except that the section was processed using the ABC method without BT. Arrowheads indicate lightly immunostained neurons. Bars: A,B = 20 pm; C = 800 pm; D,E = 40 pm. tion. After BT amplification the DAB reaction occurs rapidly. With free-floating sections, in many cases extending the time in DAB beyond 2 min resulted in an objectionable level of background staining. In the cases of antibodies that produced exceptionally clean reactions this time could be extended. It was imperative that the coloration reaction be monitored and halted when appropriate to prevent extensive background staining. Strict control of the duration of the DAB incubation appeared to be far more crucial for free-floating sections than for slide-mounted, paraffin-embedded sections, probably because sensitivity is generally greater for freefloating sections. Ten-min incubations in DAB were usually possible with slide-mounted sections.
The amplification procedure necessitates dilution of the primary antibody as compared with conventional methods. An alternative to diluting the primary antibody is decreasing the time that the tissue is exposed to the antibody. A limited number of trials with four antibodies indicated that the dilutions that were useful using conventional techniques with incubation overnight at room temperature produced approximately equivalent results with a 1-hr incubation in the primary antiserum when the biotin amplification method was used.
The three procedures that were tested for further amplifying the BT-amplified signal showed clear differences in their effectiveness. The procedure in which the tissue was recycled through the BT was the least effective. This procedure resulted in a strong signal for bVVA concentrations of 1:10,000,000 (1:lOM) but showed no reaction at all at 1:20M. The procedure in which the bWA bound to the tissue was first exposed to ABC, amplified with BT, and then detected by immunostaining for biotin produced a strong signal at 1:10M, a sparse signal at 1:20M, and no signal at 1:40M. The procedure that involved initially detecting the bWA with an antibody to biotin and then amplifying the immunoreaction with BT showed the most sensitivity. This procedure produced a strong signal at bWA dilutions of 1:40M, a sparse signal at l:bOM, and no signal at 1:80M.
Discussion
The present results demonstrate that the biotin amplification procedure has great utility for a variety of applications in neuroanatomic experiments, in lectin histochemistry, and in immunohistochemistry, because it provides greater sensitivity with reduced background staining. Moreover, in some cases the amplification makes it possible to use glutaraldehyde-fixed tissue when that would otherwise not be feasible. The usefulness of the amplification procedure is by no means limited to these techniques. The method was, after all, adapted from solid-phase assay procedures (2) . One of the attractive features of the method, aside from the increased sensitivity that it offers, is that it greatly increases the versatility of all the procedures to which it can be applied. This is because there is no reason to be confined to the HRP reaction as the final step in visualizing the sites under study. The step subsequent to the biotin amplification may also utilize avidin that is conjugated to a fluorochrome, to colloidal gold, or to another enzyme, such as alkaline phosphatase, instead of HRP. This versatility in the final step greatly increases one's options for a variety of applications, such as visualizing more than one antigen or other binding site within tissue or even within given cells.
The increase in sensitivity afforded by the biotin amplification procedure is not without its drawbacks. Just as wanted signals are amplified, so too may unwanted signals be amplified. In general, nonspecific binding of lectins and of primary antibodies appeared to be decreased by the use of much lower concentrations than those necessary to achieve similar signal strengths with conventional procedures. On the other hand, the need for highly specific reagents was made obvious in one of the procedures utilized to enhance the detection of tissue-bound biotin. In the case that involved the antibiotin step to initially detect the tissue bound bWA, it was necessary to dilute the secondary antibody 25 times more than usual to control background staining. Indeed, the sensitivity of the amplified biotin procedure is a strong reminder that nonspecific binding of secondary antibodies to the tissue can contribute significantly to background staining. With the BT procedure one should not always expect that diluting a serum will eliminate nonspecific binding. For some applications it may be necessary to use affinitypurified secondary antibodies. An alternative procedure that worked well in preliminary experiments was to use an affinity-purified, I-Wlabeled secondary antibody and to have that HRP catalyze the deposition of the BT to the tissue. Other untried possib be effective. For example, the BT method raises the possibility of achieving greater sensitivity than was previously possible with biotinylated primary antibodies ( 5 ) and of eliminating the need for secondary antibodies. In principle, the detection of the bWA in the present experiments presented a similar situation to detecting a biotinylated primary antibody, and it certainly appears that this approach is now more feasible. The biotin amplification procedure should therefore allow immunostaining protocols to become simpler and more specific without loss of sensitivity.
It does not seem likely that any of the three procedures that were tested to further amplify the BT amplified signals will be useful for ordinary histochemical procedures. The extra sensitivity they afford does not appear to be necessary for many applications. Furthermore, one does not usually wish to dilute antibodies or lectins to the point at which there are fewer antibodies or lectins in the incubation medium than there are binding sites in the tissue. This was apparently what happened when the bWA dilutions exceeded approximately 1:20M. In those cases, positive sites occurred in patches that appeared to represent subsets of the entire population of binding sites. On the other hand, the addition of a further amplification step may find a use for detecting injected biotin in neuroanatomic experiments, in in situ hybridization applications, for visualizing biotinylated ligands, for solid-phase assays, or for any other application where antigen or biotin sites are limited. The usefulness of the protocols reported herein for further amplifying the BT-amplified signal in such applications will have to be determined on a case-by-case basis.
The procedure on recycling through the BT amplification step was reported to produce approximately a 200-fold increase in sensitivity in a solid-phase assay (3) but was the least effective of the methods for further amplification that were used in the present experiments. Perhaps the reason that the same protocol was not as effective in tissue as in solid phase was that in processing tissue sections the concentration of the BT had to be reduced because of a large increase in background staining that occurred with higher concentrations of BT when the tissue was recycled.
A potential problem of the increased sensitivity afforded by the amplified biotin method is the possibility of increased background staining due to endogenous biotin. In cat this has not been a problem, but previous experience with guinea pig and rabbit brains using anti-biotin revealed some classes of neurons (e.g., pyramidal cells in the dorsal cochlear nucleus) that have fine positive granules within their cytoplasm (unpublished observations). If these sites are indeed endogenous biotin they could presumably be blocked by pre-treatment of the tissue with unlabeled avidin, followed by biotin. A better solution to the problem might be to choose a species for study that does not present the problem. The concentrations of BT and primary and secondary antibodies, as well as the duration of incubation times described herein, must be taken as tentative when other applications and perhaps other tissues are explored. The results of the present experiments indicate that methodical dilutions of the various reagents will lead to gratifying results.
